Right to Try in Jordan
How the right to try pathway operates in Jordan.
About Right to Try
US federal legislation (2018) providing an alternative pathway to investigational drugs.
How Right to Try works in Jordan
Jordan's JFDA operates a compassionate-use framework for unregistered drugs; requires physician and JFDA approval.
Patients in Jordan seeking access under Right to Try typically follow this flow: a licensed physician in Jordan issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.
Documents required in Jordan
- Physician prescription and clinical-justification letter.
- Patient identification and consent.
- Country-specific NPP/personal-import form.
- Hospital or clinic attestation where required.
Typical timeline
End-to-end 2-6 weeks in most tier 2 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.